$2.5 Million (Revenue) Plastic Surgery and MedSpa practice Located in Upper Midwest
Investment Highlights
Location: Upper Midwest
Project Name: Project Luxe
Status: New
Healthcare Segment: Plastic Surgery and MedSpa
Revenue: $2,500,000
Adjusted EBITDA: $6,364,922
M&A Healthcare Advisors is pleased to present an aesthetics practice providing Plastic Surgery and Med Spa services to patients in the Upper Midwest. The business was established over 20 years ago and offers a wide range of cosmetic surgeries and non-invasive cosmetic procedures. It operates out of 3 locations with 11 treatment rooms and 15 employees. Their main location is a stand-alone cosmetic clinic and Quad A certified surgery center.
The practice has served over 21,800 patients in its lifetime. While most services are private pay, approximately 15% of the services are covered by insurance. Non-surgical procedures include injectables, Cool Tone, Coolsculpting, Miradry, laser treatments and more. Surgical procedures include breast augmentation, liposuction, abdominoplasty, and more. The company also has a thriving testosterone practice and recently introduced Semaglutide therapies this year.
In 2022, revenues and adjusted EBITDA were approximately $2.8 million and $456K (16%) respectively. TTM revenue ending September 2023 is $2.5 million with an adjusted EBITDA of $406K (16%). For YTD (Jan-Sept.) 2023, approximately $822K (53%) of revenue was generated from surgery services and $740K (47%) from non-surgical procedures.
Our client is the company’s CEO and plastic surgeon who would like to retire near term but is open to remaining with the business long enough to ensure a successful transition. For more information and next steps, please sign our Non-Disclosure Agreement.
![Mike Moran Mike Moran](https://mahealthcareadvisors.com/wp-content/uploads/2017/01/Mike-Moran-MAHA-3-wpcf_250x250.jpg)